SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMCNet:  Research and Markets: 2013 In-depth Study 'US Personalized Cancer Genome Sequencing Market' Discusses the Various Constraints

[February 10, 2014]

Research and Markets: 2013 In-depth Study 'US Personalized Cancer Genome Sequencing Market' Discusses the Various Constraints

DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/3p53hq/us_personalized) has announced the addition of the "US Personalized Cancer Genome Sequencing Market" report to their offering.

The US personalized cancer Genome Sequencing market is primarily classified into Targeted Genome Sequencing and Whole-Genome Sequencing. The report entitled US Personalized Cancer Genome Sequencing Market takes into account the Whole-Genome Sequencing services, which is one of the most attractive sectors due to its inherent capability of high revenue generation and efficiency in terms of personalized treatment.

In order to properly analyze the virtues and significance of the US personalized cancer Whole-Genome Sequencing market, our report has effectively studied the current and futur status of cancer in the US as well as its States. In view of the fact that cancer affects some specific age groups in a significant manner, we have also investigated the age-wise statistics of the disease. To get proper insight into the market, an in-depth analysis into the high-income group population is provided so that players can have a clear picture about their potential customer base and the market to be tapped.


The WGS industry has evolved in US in the recent times, and the level and seriousness of implementation has seen drastic changes. An in-depth study of the regulatory environment governing the US personalized cancer Whole-Genome Sequencing market has also been provided. It has been found that regulations related to personalized cancer sequencing are primarily governed with the accreditation of the laboratories performing the sequencing services and analysis, and also the usage of FDA approved tests for conducting these tests. Further, the author has also discussed the various constraints faced by the industry players with suitable suggestions to overcome them.

Companies Mentioned:

- Ambry Genetics

- Beckman Coulter Genomics

- BGI Americas Corporation

- Cofactor Genomics

- Complete Genomics

- EdgeBio

- Expression Analysis

- Foundation Medicine

- Illumina

- SeqWright

For more information visit http://www.researchandmarkets.com/research/3p53hq/us_personalized

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


[ Back To Technology News's Homepage ]

OTHER NEWS PROVIDERS







Technology Marketing Corporation

800 Connecticut Ave, 1st Floor East, Norwalk, CT 06854 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2014 Technology Marketing Corporation. All rights reserved | Privacy Policy